Recurrent pregnancy losses and the role of immunotherapy
View/ Open
Date
2000Author
Omwandho, C A
Tinneberg, H R
Tumbo-Oeri, A G
Roberts, T K
Falconer, J
Type
ArticleMetadata
Show full item recordAbstract
Post implantation pregnancy losses are psychologically and economically stressful to the childbearing population. The etiology in the vast majority of cases is unknown but is partly thought to result from a break-down of the maternal tolerance to the fetoplacental unit. Immunologically based therapy remains controversial but no alternative therapy is available at the moment. This article reviews the conceived immunological basis of recurrent pregnancy losses, discussing the controversies arising, and recommending the use of intravenous immunoglobulin, IVIg, in well controlled experiments for further clinical trials.
URI
http://www.ncbi.nlm.nih.gov/pubmed/10985611http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/30392
Citation
Arch Gynecol Obstet. 2000 Jul;264(1):3-12Publisher
Department of Biochemistry, University of Nairobi
Collections
- Faculty of Health Sciences (FHS) [10387]